ALBAX
Price
$103.68
Change
-$0.62 (-0.59%)
Updated
Jul 13 closing price
Net Assets
964.17M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

ALBAX vs VSTSX

ALBAX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
ALBAX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALBAX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. ALBAX (964M). VSTSX pays higher dividends than ALBAX: VSTSX (1.07) vs ALBAX (0.71). ALBAX was incepted earlier than VSTSX: ALBAX (30 years) vs VSTSX (10 years). ALBAX (0.93) is less costly to investors than VSTSX (0.01). ALBAX is a more actively managed with annual turnover of: 4.83 vs. VSTSX (3.00). ALBAX has a lower initial minimum investment than VSTSX: ALBAX (1000) vs VSTSX (5000000000). ALBAX annual gain was more profitable for investors over the last year : 27.52 vs. VSTSX (21.48). ALBAX return over 5 years is better than : 87.18 vs. VSTSX (66.56).
ALBAXVSTSXALBAX / VSTSX
Total Expense Ratio0.930.019,300%
Annual Report Gross Expense Ratio0.930.019,300%
Fund Existence30 years10 years-
Gain YTD13.58411.205121%
Front Load5%N/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets964M2.3T0%
Annual Yield % from dividends0.711.0766%
Returns for 1 year27.5221.48128%
Returns for 3 years78.5067.06117%
Returns for 5 years87.1866.56131%
Returns for 10 years254.88239.53106%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I